Melissa K. Frey, M.D.

Gynecologic Oncology

Locations and Appointments

Accepts New Patients
Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

  • HMO
  • Medicare
  • PPO
  • EPO/POS
  • CHP
  • Blue Access
  • Blue Connection
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • CBP
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
  • HMO
  • Medicare
Personal Statement

I am dedicated to the surgical and medical management of women’s cancer and also committed to advancing clinical and translational research in this field, with a focus on cancer genetics including hereditary breast and ovarian cancer (BRCA1/2) and Lynch syndrome.

Biographical Info

Dr. Melissa Frey is an Assistant Professor of Obstetrics and Gynecology in the division of gynecologic oncology at Weill Cornell Medicine. Dr. Frey graduated magna cum laude from Duke University and earned her medical degree from Weill Cornell Medical College, graduating with honors in research. She completed her residency in Obstetrics and Gynecology at Weill Cornell Medicine / NewYork-Presbyterian. She subsequently completed her fellowship in gynecologic oncology at New York University Langone Medical Center.

Dr. Frey specializes in all aspects of gynecologic oncology including surgical management and chemotherapy for cancers of the uterus, ovary, cervix, vulva and vagina. She is extensively trained in minimally invasive surgical approaches using laparoscopic and robotic platforms for gynecologic cancer and complex benign gynecologic conditions.

Dr. Frey has received numerous awards for her clinical excellence, surgical expertise and medical research, including the Siegel Family Faculty Development Prize, Sarnoff Research Foundation Fellowship, Alan von Kreuter Cancer Research Prize, Society of Laparoendoscopic Surgeons Outstanding Laparoendoscopic Resident Surgeon Award, Special Resident in Minimally Invasive Gynecology Award, Jerome E. Seiler Memorial Superior Skill in Advanced Gynecologic Surgery Award and multiple teaching awards.

Dr. Frey’s research focuses on genetics and genomics in gynecologic cancer. She has presented her research at national and international meetings and has more than 50 publications in peer-reviewed scientific journals. Much of her research has focused on genetic syndromes that predispose to gynecologic cancer including hereditary breast and ovarian cancer (BRCA1/BRCA2) and Lynch syndrome.

Dr. Frey is also committed to providing treatment to underserved populations internationally. She has traveled to Central America, South America and Africa to provide basic health care and surgical management for gynecologic disease. 

Board Certifications
American Board of Obstetrics & Gynecology
American Board of Obstetrics & Gynecology (Gynecologic Oncology)
Clinical Expertise
Uterine Cancer
Cervical Cancer
Ovarian Cancer
Vaginal Cancer
Robotic Surgery
Chemotherapy
Laparoscopic Surgery
Minimally Invasive Surgery
Vulvar Cancer
Endometrial Cancer
Languages
English
Education 
  • M.S.
    Weill Graduate School of Medical Sciences of Cornell University
    2022
  • M.D.
    Weill Cornell Medical College, Cornell University
    2009
  • B.A.
    Duke University
    2004
Appointments 
  • Assistant Attending Obstetrician and Gynecologist
    NewYork-Presbyterian Hospital
  • Assistant Professor of Obstetrics and Gynecology
    Weill Cornell Medical College, Cornell University
Videos

How Research Helps Us Treat Gynecologic Cancers | Dr. Melissa K. Frey | Weill Cornell Medicine

From the field to the exam room | Dr. Melissa Frey | Weill Cornell Medicine

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

No External Relationships Reported